Janus Henderson Investors: Healthcare Sector Evolution
The healthcare sector encountered high political uncertainty in 2025 but witnessed positive developments. Pharmaceutical companies gained transparency in customs and steady drug approvals. Biotechnology firms benefited from clinical progress and heightened transaction activity, including billion-dollar acquisitions. Andy Acker, Portfolio Manager at Janus Henderson Investors, remains optimistic about the future. He believes healthcare stocks continue to trade at relatively attractive price-to-earnings ratios even after recent rallies. Anticipated developments in the biotech field include rapid data evaluation in key treatment areas like cancer and neurological disorders, along with specialized regions like myotonic dystrophy and achondroplasia. Notably, the sector maintains a strong commitment to innovations, potentially driving long-term profit growth and share price increases.
About Janus Henderson
Janus Henderson Group is a leading global active asset manager, aiding clients in achieving outstanding financial results through distinctive insights, disciplined investment decisions, and top-tier service. As of June 30, 2025, Janus Henderson manages approximately $457 billion in assets (around €390 billion) with 2,000+ employees and offices in 25 cities globally. The London-based company is listed on the New York Stock Exchange (NYSE). The views expressed in this publication are those of the author and may differ from views of others at Janus Henderson Investors. References to specific securities do not constitute recommendations for buying, selling, or holding securities, investment strategies, or market sectors and should not be viewed as profitable advice. Janus Henderson Investors, its affiliates, or employees may hold positions in mentioned securities. Past performance does not guarantee future returns. Investments can rise or fall, and the original investment amount may not be fully returned. The information provided does not serve as investment advice, and there is no assurance that past trends will continue or forecasts will materialize. This press release is solely intended for media representatives and should not be used by individual investors, financial advisors, or institutional investors. We may store telephone calls for mutual protection, improving customer service, and regulatory record-keeping purposes. All opinions and judgments in this information are subject to change without prior notice. Issued by Janus Henderson Investors; Janus Henderson Investors is the label under which investment products and services are provided by Janus Henderson Investors International Limited, Janus Henderson Investors UK Limited, Janus Henderson Fund Management UK Limited, Tabula Investment Management Limited, and Janus Henderson Investors Europe S.A. among others.
…
This article was automatically generated from an e-mail sent to the altii editorial system. Please note that the content has not been checked for accuracy, but we always endeavor to provide you with interesting and relevant information.